Caming, Xyle Drix .

HRN: 28-99-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/18/2026
05/25/2026
PO
4ml
Q8
T/c Begining CNS Abscess
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines